Initial phase I study of XR5944, a novel DNA and RNA targeting agent, and Related American Society of Clinical Oncology Trial Abstracts

Posted on August 28, 2004 by Barry Sugarman

Please see this link:

http://www.asco.org/ac/1,1003,_12-002636-00_18-0026-00_19-001429,00.asp

Leave a Reply Cancel reply